Clinical Trials Browser

Phase 2 × Clear-cell metastatic renal cell carcinoma × Sunitinib × Clear all

NCT02960906 2021-04-26

BIONIKK

Phase 2 Completed

Clear-cell metastatic renal cell carcinoma

NCT01391130 2019-07-23

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Phase 2 Terminated

110 enrolled 14 charts

Clear-cell metastatic renal cell carcinoma, Neoplasm Metastasis, Neoplasms

NCT01499121 2018-03-06

Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule

Phase 2 Completed

Clear-cell metastatic renal cell carcinoma